The following studies are now seeking participants. AstraZeneca/TRITON (D419ML00003) - Maurice Willis, M.D. The purpose of the study is to assess the efficacy of durvalumab plus tremelimumab in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback